Neurelis, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved VALTOCO® (diazepam nasal spray) ...

In this younger patient population, diazepam nasal spray was readily absorbed and demonstrated a consistent PK profile with that of older children and adults aged 6 to 59 years.

The company is developing psychedelics for depression, and hopes to go public within a year of its next published results, per documents seen by BI.

The U.S. Food and Drug Administration classified a recent nasal wash recall for SinuCleanse. The recall, initiated due to microbial contamination, has been officially labeled a Class 1 recall ...